GLP-1 Portfolio Diversification

Eli Lilly Enters Vaccine Market with $3.8B Triple Biotech Acquisition

Fueled by GLP-1 Cash Reserves, Lilly Buys Curevo, LimmaTech, and Vaccine Company in Major Infectious Disease Pivot INDIANAPOLIS, IN —…

Read More »